Search

Nucleic acids represent the alphabet of the cellular language and through their sequence and topology regulate vital cellular functions. In recent years, it has been found that many variations from the Watson–Crick duplex structure play key roles in many cellular processes. Examples are hairpins, cruciforms, parallel-stranded duplexes, triplexes, G-quadruplexes, and the i-motif. These structures can be formed by nucleotide sequences distributed throughout the whole human genome, their location is not random and often associated with human diseases. These complexes are formed from one to four strands, stabilized by base stacking and hydrogen bond interactions, with a variety of non-standard pairings. For instance, DNA triplexes can present G:G-C, A:A-T, C:G-C, and T:A-T pairings, with two strands in the standard Watson–Crick duplex structure (i.e. G-C and A-T) and the third one lying in the major groove of the duplex. In contrast, G-quadruplexes are four-stranded structures stabilized by stacking of two or more guanine tetrads (Figure 1). These examples highlight the structural polymorphism of DNA and suggest that other structures might exist, perhaps with specific cellular functions that are, to date, unknown. Herein, using metadynamics simulations, we have identified a stable folding intermediate of the thrombin binding aptamer (TBA) quadruplex. This intermediate is characterized by a “G-triplex” structure, having G:G:G triad planes stabilized by an array of Hoogsteen-like hydrogen-bonds (Figure 1). This kind of structure has been already hypothesized in other investigations on different DNA sequences, but never experimentally proven. Herein, for the first time, we have structurally and thermodynamically characterized this DNA structural motif, through a combination of biophysical experiments. Well-tempered metadynamics simulations have been used to study the folding of TBA, which is a 15-mer oligonucleotide (5’-dGGTTGGTGTGGTTGG-3’) organized in an anti-parallel monomolecular G-quadruplex with a chairlike structure (Figure 2a). This structure consists of two Gtetrads, able to coordinate a metal ion at the center, connected by two TT loops and a single TGT loop. Metadynamics accelerates the sampling, adding a bias on a few degrees of freedom of the system, called collective variables (CVs). In such a way, long time scale events, such as ligand/protein docking or protein/DNA folding, can be sampled in an affordable computational time and the free energy surface (FES) of the process can be computed. In the present case, the FES was calculated as a function of two CVs, the radius of gyration CV defined by the oxygen atoms of the guanines forming the G-tetrads and a second CV that counts the number of hydrogen bonds between these guanines (see Supporting Information). Looking at the FES obtained after approximately 80 ns of metadynamics simulation, three main energy minima can be identified (Figure 2b). The deepest one, basin A, corresponds to the experimental G-quadruplex structure of TBA. In the second minimum, basin B, TBA shows a partial opening of the 3’ end with residue G15

Streptococcus gordonii and Streptococcus sanguinis, commensal bacteria present in the oral cavity of healthy individuals, upon entry into the bloodstream can become pathogenic, causing infective endocarditis (IE). Sialic acid-binding serine-rich repeat adhesins on the microbial surface represent an important factor of successful infection to cause IE. They contain Siglec-like binding regions (SLBRs) that variously recognize different repertoires of O-glycans, with some strains displaying high selectivity and others broader specificity. We here dissect at an atomic level the mechanism of interaction of SLBR-B and SLBR-H from S. gordonii with a multivarious approach that combines NMR spectroscopy and computational and biophysical studies. The binding pockets of both SLBRs are broad enough to accommodate extensive interactions with sialoglycans although with key differences related to strain specificity. Furthermore, and significantly, the pattern of interactions established by the SLBRs are mechanistically very different from those reported for mammalian Siglecs despite them having a similar fold. Thus, our detailed description of the binding modes of streptococcal Siglec-like adhesins sparks the development of tailored synthetic inhibitors and therapeutics specific for Streptococcal adhesins to counteract IE, without impairing the interplay between Siglecs and glycans., We here present a detailed molecular description of sialoglycans recognition by Siglec-like adhesins from S. gordonii opening the venue for the design of specific inhibitors to influence the propensity of streptococci to cause infective endocarditis.

HMGB1 is a ubiquitous non-histone protein, which biological effects depend on its expression and subcellular location. Inside the nucleus, HMGB1 is engaged in many DNA events such as DNA repair, transcription and telomere maintenance. HMGB1 has been reported to bind preferentially to bent DNA as well as to noncanonical DNA structures like 4-way junctions and, more recently, to G-quadruplexes. These are four-stranded conformations of nucleic acids involved in important cellular processes, including telomere maintenance. In this frame, G-quadruplex recognition by specific proteins represents a key event to modulate physiological or pathological pathways. Herein, to get insights into the telomeric G-quadruplex DNA recognition by HMGB1, we performed detailed biophysical studies complemented with biological analyses. The obtained results provided information about the molecular determinants for the interaction and showed that the structural variability of human telomeric G-quadruplex DNA may have significant implications in HMGB1 recognition. The biological data identified HMGB1 as a telomere-associated protein in both telomerase-positive and -negative tumor cells and showed that HMGB1 gene silencing in such cells induces telomere DNA damage foci. Altogether, these findings provide a deeper understanding of telomeric G-quadruplex recognition by HMGB1 and suggest that this protein could actually represent a new target for cancer therapy.

The inhibition of the PD-1/PD-L1 axis by monoclonal antibodies has achieved remarkable success in treating a growing number of cancers. However, a novel class of small organic molecules, with BMS-202 (1) as the lead, is emerging as direct PD-L1 inhibitors. Herein, we report a series of 2,4,6-tri- and 2,4-disubstituted 1,3,5-triazines, which were synthesized and assayed for their PD-L1 binding by NMR and homogeneous time-resolved fluorescence. Among them, compound 10 demonstrated to strongly bind with the PD-L1 protein and challenged it in a co-culture of PD-L1 expressing cancer cells (PC9 and HCC827 cells) and peripheral blood mononuclear cells enhanced antitumor immune activity of the latter. Compound 10 significantly increased interferon γ release and apoptotic induction of cancer cells, with low cytotoxicity in healthy cells when compared to 1, thus paving the way for subsequent preclinical optimization and medical applications.

Glioblastoma Multiforme (GBM) is a highly invasive primary brain tumour characterized by chemo- and radio-resistance and poor overall survival. GBM can present an aberrant functionality of p53, caused by the overexpression of the murine double minute 2 protein (MDM2) and its analogue MDM4, which may influence the response to conventional therapies. Moreover, tumour resistance/invasiveness has been recently attributed to an overexpression of the chemokine receptor CXCR4, identified as a pivotal mediator of glioma neovascularization. Notably, CXCR4 and MDM2-4 cooperate in promoting tumour invasion and progression. Although CXCR4 actively promotes MDM2 activation leading to p53 inactivation, MDM2-4 knockdown induces the downregulation of CXCR4 gene transcription. Our study aimed to assess if the CXCR4 signal blockade could enhance glioma cells' sensitivity to the inhibition of the p53-MDMs axis. Rationally designed inhibitors of MDM2/4 were combined with the CXCR4 antagonist, AMD3100, in human GBM cells and GBM stem-like cells (neurospheres), which are crucial for tumour recurrence and chemotherapy resistance. The dual MDM2/4 inhibitor RS3594 and the CXCR4 antagonist AMD3100 reduced GBM cell invasiveness and migration in single-agent treatment and mainly in combination. AMD3100 sensitized GBM cells to the antiproliferative activity of RS3594. It is noteworthy that these two compounds present synergic effects on cancer stem components: RS3594 inhibited the growth and formation of neurospheres, AMD3100 induced differentiation of neurospheres while enhancing RS3594 effectiveness preventing their proliferation/clonogenicity. These results confirm that blocking CXCR4/MDM2/4 represents a valuable strategy to reduce GBM proliferation and invasiveness, acting on the stem cell component too.

Summary The Tn antigen is a well-known tumor-associated carbohydrate determinant, often incorporated in glycopeptides to develop cancer vaccines. Herein, four copies of a conformationally constrained mimetic of the antigen TnThr (GalNAc-Thr) were conjugated to the adjuvant CRM197, a protein licensed for human use. The resulting vaccine candidate, mime[4]CRM elicited a robust immune response in a triple-negative breast cancer mouse model, correlated with high frequency of CD4+ T cells and low frequency of M2-type macrophages, which reduces tumor progression and lung metastasis growth. Mime[4]CRM-mediated activation of human dendritic cells is reported, and the proliferation of mime[4]CRM-specific T cells, in cancer tissue and peripheral blood of patients with breast cancer, is demonstrated. The locked conformation of the TnThr mimetic and a proper presentation on the surface of CRM197 may explain the binding of the conjugate to the anti-Tn antibody Tn218 and its efficacy to fight cancer cells in mice., Graphical Abstract, Highlights • Structurally simple vaccine candidate reduces BC tumor size and delays lung metastasis • TnThr mimetic, fused to CRM197 adjuvant, is able to elicit T and B immune responses • TnThr mimetic-based vaccine candidate able to activate human DCs • The vaccine candidate recruits T helper CD4+ in the tumor microenvironment, Medical Biochemistry; Immunology; Cancer

Synthetic sulfonamide derivatives are a class of potent matrix metalloproteinase inhibitors (MMPI) that have potential for the treatment of diseases related to uncontrolled expression of these enzymes. The lack of selectivity of the large majority of such inhibitors, leading to the inhibition of MMPs in tissues other than the targeted one, has dramatically reduced the therapeutic interest in MMPIs. The recent development of efficient drug delivery systems that allow the transportation of a selected drug to its site of action has opened the way to new perspectives in the use of MMPIs. Here, a PAMAM-based divalent dendron with two sulfonamidic residues was synthesized. This nanomolar inhibitor binds to the catalytic domain of two MMPs as well as to the transmembrane human carbonic anhydrases (hCAs) XII, which is present in the eye and considered an antiglaucoma target. In the animal model of an experimental dry eye, no occurrence of dotted staining in eyes treated with our inhibitor was observed, indicating no symptoms of corneal desiccation.